SAN DIEGO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or the “Company”), an international healthcare solutions company targeting oncological ...
Pune, India, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Enzyme-Linked Immunosorbent Assay (ELISA) is a diagnostic technique that helps detect antibodies or infectious agents present in a biological fluid.
The global ELISA analyzer market size is expected to reach USD 754.38 million by 2030 expanding at a CAGR of 3.7% from 2023 to 2030. The market is expected to witness a lucrative growth rate during ...
ELISAs are considered one of the most useful secondary or tertiary type assays in drug discovery, because they elucidate specific cellular pathways and associated mechanisms of action for target genes ...
Enzyme Linked Immunosorbent Assays (ELISAs) are commonly used to quantify biomarkers in serum, plasma and cell culture supernates. These samples contain a variety of factors that can interfere with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results